Drug Shortage Report for MYLAN-NAPROXEN/ESOMEPRAZOLE MR
Report ID | 13528 |
Drug Identification Number | 02443449 |
Brand name | MYLAN-NAPROXEN/ESOMEPRAZOLE MR |
Common or Proper name | NAPROXEN/ESOMEPRAZOLE MR |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | ESOMEPRAZOLE NAPROXEN |
Strength(s) | 20MG 500MG |
Dosage form(s) | TABLET (IMMEDIATE AND DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 60BT |
ATC code | M01AE |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2019-05-15 |
Actual start date | |
Estimated end date | 2019-05-22 |
Actual end date | 2019-05-22 |
Shortage status | Resolved |
Updated date | 2019-05-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v45 | 2018-10-10 | English | Compare |
v44 | 2018-10-09 | French | Compare |
v43 | 2018-10-09 | English | Compare |
v42 | 2018-10-05 | English | Compare |
v41 | 2018-10-03 | French | Compare |
v40 | 2018-10-03 | English | Compare |
v39 | 2018-10-01 | French | Compare |
v38 | 2018-10-01 | English | Compare |
v37 | 2018-09-25 | English | Compare |
v36 | 2018-09-24 | French | Compare |
v35 | 2018-09-24 | English | Compare |
v34 | 2018-09-20 | French | Compare |
v33 | 2018-09-20 | English | Compare |
v32 | 2018-09-17 | French | Compare |
v31 | 2018-09-17 | English | Compare |
v30 | 2018-09-13 | French | Compare |
v29 | 2018-09-13 | English | Compare |
v28 | 2018-09-13 | English | Compare |
v27 | 2018-07-26 | English | Compare |
v26 | 2018-07-25 | French | Compare |